Somatostatin receptor ligands (SRLs) represent a true milestone in the medical therapy for acromegaly. The first-generation SRLs (FG-SRLs). octreotide and lanreotide. have demonstrated good efficacy in disease control and tumor shrinkage. https://yeswellneses.shop/product-category/fountains/